BP1.4979

Bioprojet · Phase 2 active Small molecule

At a glance

Generic name	BP1.4979
Sponsor	Bioprojet
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Proof of Concept Study on BP1.4979 Effect on Essential Tremor (PHASE2)
Pilot Study on BP1.4979 Effect on Binge Eating Disorders (PHASE2)
Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation (PHASE2)
Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome (PHASE2)
Efficacy and Safety of BP1.4979 in Smoking Cessation (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BP1.4979 CI brief — competitive landscape report
BP1.4979 updates RSS · CI watch RSS
Bioprojet portfolio CI